Platinum-resistant Ovarian Cancer Recruiting Phase 1 / 2 Trials for Niraparib (DB11793)

Also known as: Platinum drug resistant Ovarian cancer / Platinum-resistant Ovarian Cancer (PROC) / Platinum Resistant Ovarian Cancer

IndicationStatusPhase
DBCOND0068919 (Platinum-resistant Ovarian Cancer)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05198804A Study of ZN-c3 and Niraparib in Subjects With Platinum-Resistant Ovarian CancerTreatment